Anne Sophie Kubasch, Specialist Physician for Internal Medicine, Hematology and Oncology at University Leipzig, shared on X:
“Yesterday, we presented the results of the LUCAS and CANFIRE trials at ASH 2024 in San Diego (Poster ID: 199032). Our studies investigated IRAK4 and IL-1β blockade in lower-risk MDS to address inflammation-driven ineffective hematopoiesis. “